Apimeds Pharmaceuticals US, Inc. (APUS)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.67+4.37%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-20.2M

EPS

$-11.77

Market cap

$3.2M

Forward P/E

0.0

P/B

0.03

Book value

$0.65

EPS (TTM)

$-35.98

52-week high

$40.31

52-week low

$2.09

50-day MA

$5.15

200-day MA

$13.61

Insiders

58.70%

Institutions

2.83%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Apimeds Pharmaceuticals US, Inc. — free to start.

Data updated 2026-09-18.